Schumer Calling on CBP, FDA to Stop Chinese Substandard Nonprescription Drugs
Senate Majority Leader Chuck Schumer, D-N.Y., is complaining that he has not gotten a response from the FDA and CBP to a letter he sent in November asking what the agencies are doing to stop unsafe non-prescription drugs imported from…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
China (see 1911180056). Schumer, who did a press event Feb. 10 in western New York to highlight the issue, noted that his previous press event in November got results locally, but that's not enough. “After we pushed Dollar Tree stores in Manhattan on this issue, they were seen clearing the shelves, but we can’t do this store-by-store, the company needs to do it on its own and the Food and Drug Administration needs to keep the pressure on. The stores across Western New York should not be allowed to continue receiving these questionable or even dangerous over-the-counter drugs, and that’s where Customs and Border Protection need to hold them to account, too,” he said. CBP declined to comment on why it has not responded yet.